Reviva Pharmaceuticals Holdings, Inc.(RVPH)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RVPH Reviva Pharmaceuticals Holdings, Inc.

交易中 11-19 12:34:56 EST

1.36

+0.09

+6.69%

最高1.37	最低1.27	成交量28.38万
今开1.28	昨收1.27	日振幅7.87%
总市值4,531万	流通市值3,130万	总股本3,344万
成交额37.62万	换手率1.23%	流通股本2,310万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"RVPH","market":"US","secType":"STK","nameCN":"Reviva Pharmaceuticals Holdings, Inc.","latestPrice":1.355,"timestamp":1732037459012,"preClose":1.27,"halted":0,"volume":283843,"delay":0,"floatShares":23102313,"shares":33441199,"eps":-1.118167,"marketStatus":"交易中","marketStatusCode":2,"change":0.085,"latestTime":"11-19 12:34:56 EST","open":1.28,"high":1.37,"low":1.27,"amount":376204.1213693,"amplitude":0.07874,"askPrice":1.36,"askSize":850,"bidPrice":1.35,"bidSize":109,"shortable":3,"etf":0,"ttmEps":-1.118167,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1732050000000},"adr":0,"adjPreClose":1.27,"postHourTrading":{"tag":"盘后","latestPrice":1.2701,"preClose":1.27,"latestTime":"19:53 EST","volume":6280,"amount":7924.0204,"timestamp":1731977603430},"volumeRatio":0.406589,"impliedVol":1.0254,"impliedVolPercentile":0.6071},"requestUrl":"/m/hq/s/RVPH/tweets","defaultTab":"tweets","newsList":[{"id":"2484926259","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 早盘股价大涨5.12%报1.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484926259","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484926259?lang=zh_cn&edition=full","pubTime":"2024-11-19 23:24","pubTimestamp":1732029898,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日23时24分，Reviva Pharmaceuticals Holdings, Inc.股票出现异动，股价快速上涨5.12%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体跌幅为1.35%。其相关个股中，Exicure, Inc.、Dermata Therapeutics Inc C/Wts 、Fresh2 Group Limited涨幅较大，Tff Pharmaceuticals, Inc.、Exicure, Inc.、Hcw Biologics Inc.较为活跃，换手率分别为704.29%、101.77%、100.28%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为81.67%、62.18%、52.14%。Reviva Pharmaceuticals Holdings, Inc.公司简介：Reviva Pharmaceuticals Holdings Inc 是一家后期的制药公司，致力于发现、开发并寻求商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119232459a2460952&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119232459a2460952&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVPH","BK4007"],"gpt_icon":0},{"id":"2484867679","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 早盘大幅上涨6.67%报1.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484867679","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484867679?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:32","pubTimestamp":1731940353,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时32分，Reviva Pharmaceuticals Holdings, Inc.股票出现异动，股价快速上涨6.67%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。其相关个股中，Hcw Biologics Inc.、冠科美博、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃，换手率分别为516.52%、202.59%、187.83%，振幅较大的相关个股有Hcw Biologics Inc.、冠科美博、Biomx Inc.，振幅分别为50.92%、34.31%、19.34%。Reviva Pharmaceuticals Holdings, Inc.公司简介：Reviva Pharmaceuticals Holdings Inc 是一家后期的制药公司，致力于发现、开发并寻求商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118223233971a7283&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118223233971a7283&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","RVPH"],"gpt_icon":0},{"id":"2483497379","title":"Reviva Pharmaceuticals Holdings, Inc. 公布本季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2483497379","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483497379?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:01","pubTimestamp":1731679293,"startTime":"0","endTime":"0","summary":"Reviva Pharmaceuticals Holdings, Inc. 公布本季度业绩 - 收益摘要Reviva Pharmaceuticals Holdings, Inc.RVPH.OQ报告本季度调整后每股亏损25美分，高于去年同期的每股-44美分。六位分析师对该季度的平均预期是每股亏损 25 美分。Reviva Pharmaceuticals Holdings, Inc. 本季度股价下跌了 16.0%，今年迄今为止下跌了 76.5%。华尔街对 Reviva Pharmaceuticals Holdings, Inc. 的 12 个月目标价中位数为 15.00 美元。本摘要由 LSEG 11 月 15 日 02:01 p.m. UTC 数据机器生成。如有任何其他问题或反馈，请联系 RefinitivNewsSupport@thomsonreuters.com。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241115:nL4S3MM0Z1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVPH","BK4007"],"gpt_icon":0},{"id":"2483379492","title":"Reviva Pharmaceuticals Holdings, Inc. 公布本季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2483379492","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483379492?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:01","pubTimestamp":1731679293,"startTime":"0","endTime":"0","summary":"Reviva Pharmaceuticals Holdings, Inc. 公布本季度业绩 - 收益摘要Reviva Pharmaceuticals Holdings, Inc.RVPH.OQ报告本季度调整后每股亏损25美分，高于去年同期的每股-44美分。六位分析师对该季度的平均预期是每股亏损 25 美分。Reviva Pharmaceuticals Holdings, Inc. 本季度股价下跌了 16.0%，今年迄今为止下跌了 76.5%。华尔街对 Reviva Pharmaceuticals Holdings, Inc. 的 12 个月目标价中位数为 15.00 美元。本摘要由 LSEG 11 月 15 日 02:01 p.m. UTC 调制解调器器生成。如有任何其他问题或反馈，请联系 RefinitivNewsSupport@thomsonreuters.com。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241115:nL4T3MM0Z1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVPH","BK4007"],"gpt_icon":0},{"id":"2483881054","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 早盘快速拉升5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483881054","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483881054?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:34","pubTimestamp":1731508452,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时34分，Reviva Pharmaceuticals Holdings, Inc.股票出现异动，股价急速上涨5.30%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Tharimmune, Inc.较为活跃，换手率分别为332.88%、183.48%、85.74%，振幅较大的相关个股有Immunoprecise Antibodies Ltd.、Exicure, Inc.、Sangamo Therapeutics, Inc.，振幅分别为14.89%、14.60%、14.39%。Reviva Pharmaceuticals Holdings, Inc.公司简介：Reviva Pharmaceuticals Holdings Inc 是一家后期的制药公司，致力于发现、开发并寻求商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223412abbddee5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223412abbddee5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","RVPH"],"gpt_icon":0},{"id":"2482275825","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 大幅拉升5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482275825","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482275825?lang=zh_cn&edition=full","pubTime":"2024-11-12 01:14","pubTimestamp":1731345245,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日01时14分，Reviva Pharmaceuticals Holdings, Inc.股票出现异动，股价大幅上涨5.03%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。其相关个股中，Cero Therapeutics Holdings, Inc.、Aligos Therapeutics, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Cero Therapeutics Holdings, Inc.、Revelation Biosciences, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为689.55%、493.68%、205.63%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Aligos Therapeutics, Inc.、Lakeshore Biopharma Co., Ltd，振幅分别为123.43%、72.42%、61.39%。Reviva Pharmaceuticals Holdings, Inc.公司简介：Reviva Pharmaceuticals Holdings Inc 是一家后期的制药公司，致力于发现、开发并寻求商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111201140598e41db7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111201140598e41db7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","RVPH"],"gpt_icon":0},{"id":"2482485119","title":"Reviva Pharmaceuticals Holdings, Inc.预计每股亏损25美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2482485119","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482485119?lang=zh_cn&edition=full","pubTime":"2024-11-09 00:02","pubTimestamp":1731081751,"startTime":"0","endTime":"0","summary":"Reviva Pharmaceuticals Holdings, Inc.预计每股亏损25美分 - 财报前瞻Reviva Pharmaceuticals Holdings, Inc. RVPH.OQ RVPH.O预计在11月12日公布截至0001年1月1日的业绩时，季度收入将没有变化(预计)。华尔街对 Reviva Pharmaceuticals Holdings, Inc. 的 12 个月目标价中位数为 15.00 美元，高于上一次 0.94 美元的收盘价。11月8日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。如有任何其他问题或反馈，请联系 RefinitivNewsSupport@thomsonreuters.com。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL4S3MF1UK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVPH"],"gpt_icon":0},{"id":"2481048861","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 早盘大幅上涨5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481048861","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481048861?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:34","pubTimestamp":1731076464,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时34分，Reviva Pharmaceuticals Holdings, Inc.股票出现波动，股价急速上涨5.54%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Fortrea Holdings Inc.、Poseida Therapeutics, Inc.涨幅较大，Elevai Labs, Inc.、Matinas Biopharma Holdings, Inc.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为398.27%、17.86%、15.00%，振幅较大的相关个股有Cardiff Oncology, Inc.、Rigel Pharmaceuticals, Inc.、Anebulo Pharmaceuticals, Inc.，振幅分别为18.09%、16.52%、14.96%。Reviva Pharmaceuticals Holdings, Inc.公司简介：Reviva Pharmaceuticals Holdings Inc 是一家后期的制药公司，致力于发现、开发并寻求商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108223425abae3ddb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108223425abae3ddb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","RVPH"],"gpt_icon":0},{"id":"2481946635","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 股价大跌5.78%报0.941美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481946635","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481946635?lang=zh_cn&edition=full","pubTime":"2024-11-06 01:35","pubTimestamp":1730828146,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日01时35分，Reviva Pharmaceuticals Holdings, Inc.股票出现波动，股价大幅下跌5.78%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体涨幅为1.63%。Reviva Pharmaceuticals Holdings, Inc.公司简介：Reviva Pharmaceuticals Holdings Inc 是一家后期的制药公司，致力于发现、开发并寻求商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106013547a2191a2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106013547a2191a2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","RVPH"],"gpt_icon":0},{"id":"2480058404","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 早盘急速上涨5.37%报1.030美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480058404","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480058404?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:52","pubTimestamp":1730731940,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时52分，Reviva Pharmaceuticals Holdings, Inc.股票出现异动，股价急速拉升5.37%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Neurogene Inc.、Disc Medicine, Inc.、Tenaya Therapeutics, Inc.涨幅较大，Nls Pharmaceutics Ltd.、Elevai Labs, Inc.、Gri Bio, Inc.较为活跃，换手率分别为254.67%、195.74%、55.00%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Briacell Therapeutics Corp C/Wts 24/02/2025、Nls Pharmaceutics Ltd.，振幅分别为31.90%、29.83%、25.56%。Reviva Pharmaceuticals Holdings, Inc.公司简介：Reviva Pharmaceuticals Holdings Inc 是一家后期的制药公司，致力于发现、开发并寻求商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104225220971a42c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104225220971a42c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","RVPH"],"gpt_icon":0},{"id":"2480872618","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 快速跳水5.36%报1.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480872618","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480872618?lang=zh_cn&edition=full","pubTime":"2024-11-01 22:42","pubTimestamp":1730472145,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日22时42分，Reviva Pharmaceuticals Holdings, Inc.股票出现异动，股价快速下跌5.36%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.48%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Revolution Medicines Inc C/Wts 17/12/2026 、Ensysce Biosciences, Inc.涨幅较大，Theriva Biologics, Inc.、Gri Bio, Inc.、Ensysce Biosciences, Inc.较为活跃，换手率分别为3239.25%、772.99%、358.52%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Immatics N V C/Wts 01/07/2025 、Theriva Biologics, Inc.，振幅分别为122.67%、60.77%、56.84%。Reviva Pharmaceuticals Holdings, Inc.公司简介：Reviva Pharmaceuticals Holdings Inc 是一家后期的制药公司，致力于发现、开发并寻求商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101224226ab931b8b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101224226ab931b8b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVPH","BK4007"],"gpt_icon":0},{"id":"2479033773","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 早盘急速下挫5.19%报1.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479033773","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479033773?lang=zh_cn&edition=full","pubTime":"2024-10-31 21:52","pubTimestamp":1730382743,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日21时52分，Reviva Pharmaceuticals Holdings, Inc.股票出现异动，股价快速下跌5.19%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体跌幅为2.40%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Ocean Biomedical Inc C/Wts 14/02/2028 、Aerovate Therapeutics, Inc.涨幅较大，Evogene Ltd.、Aditxt, Inc.、Palisade Bio, Inc.较为活跃，换手率分别为212.20%、204.43%、153.43%，振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为39.30%、28.17%、21.98%。Reviva Pharmaceuticals Holdings, Inc.公司简介：Reviva Pharmaceuticals Holdings Inc 是一家后期的制药公司，致力于发现、开发并寻求商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031215223a2023333&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031215223a2023333&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVPH","BK4007"],"gpt_icon":0},{"id":"2479454603","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 临近收盘急速上涨5.26%报1.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479454603","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479454603?lang=zh_cn&edition=full","pubTime":"2024-10-29 04:00","pubTimestamp":1730145633,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日04时00分，Reviva Pharmaceuticals Holdings, Inc.股票出现波动，股价急速拉升5.26%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。其相关个股中，Monte Rosa Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cardio Diagnostics Holdings Inc.涨幅较大，Tc Biopharm  Plc、Genprex, Inc.、Monte Rosa Therapeutics, Inc.较为活跃，换手率分别为752.77%、507.36%、154.07%，振幅较大的相关个股有Monte Rosa Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为127.61%、87.13%、84.14%。Reviva Pharmaceuticals Holdings, Inc.公司简介：Reviva Pharmaceuticals Holdings Inc 是一家后期的制药公司，致力于发现、开发并寻求商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029040033ab7c6881&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029040033ab7c6881&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","RVPH"],"gpt_icon":0},{"id":"2478795367","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 股价大涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478795367","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478795367?lang=zh_cn&edition=full","pubTime":"2024-10-25 23:54","pubTimestamp":1729871683,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日23时54分，Reviva Pharmaceuticals Holdings, Inc.股票出现波动，股价大幅拉升5.26%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。其相关个股中，Iterum Therapeutics Plc、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Nutriband Inc C/Wts 涨幅较大，180 Life Sciences Corp.、Elevai Labs, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为809.88%、740.16%、221.27%，振幅较大的相关个股有Qualigen Therapeutics, Inc.、Iterum Therapeutics Plc、Elevai Labs, Inc.，振幅分别为91.58%、90.60%、85.14%。Reviva Pharmaceuticals Holdings, Inc.公司简介：Reviva Pharmaceuticals Holdings Inc 是一家后期的制药公司，致力于发现、开发并寻求商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025235443ab74473b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025235443ab74473b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVPH","BK4007"],"gpt_icon":0},{"id":"2477531675","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 急速跳水6.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477531675","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477531675?lang=zh_cn&edition=full","pubTime":"2024-10-23 22:09","pubTimestamp":1729692562,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日22时09分，Reviva Pharmaceuticals Holdings, Inc.股票出现波动，股价大幅跳水6.25%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体跌幅为1.21%。其相关个股中，Cns Pharmaceuticals, Inc.、Tevogen Bio Holdings Inc.、Virax Biolabs Group Limited涨幅较大，Virax Biolabs Group Limited、Cns Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为1508.98%、775.87%、332.28%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Tevogen Bio Holdings Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为71.86%、68.32%、64.55%。Reviva Pharmaceuticals Holdings, Inc.公司简介：Reviva Pharmaceuticals Holdings Inc 是一家后期的制药公司，致力于发现、开发并寻求商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023220922971a1d1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023220922971a1d1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","RVPH"],"gpt_icon":0},{"id":"2477238355","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 股价大跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477238355","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477238355?lang=zh_cn&edition=full","pubTime":"2024-10-22 22:32","pubTimestamp":1729607534,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日22时32分，Reviva Pharmaceuticals Holdings, Inc.股票出现异动，股价快速下跌5.33%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。其相关个股中，Ensysce Biosciences, Inc.、Genprex, Inc.、Sangamo Therapeutics, Inc.涨幅较大，Genprex, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为4078.61%、3129.18%、1897.31%，振幅较大的相关个股有Ensysce Biosciences, Inc.、Aptevo Therapeutics Inc.、Genprex, Inc.，振幅分别为140.78%、99.41%、81.46%。Reviva Pharmaceuticals Holdings, Inc.公司简介：Reviva Pharmaceuticals Holdings Inc 是一家后期的制药公司，致力于发现、开发并寻求商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022223214a1e2d2a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022223214a1e2d2a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVPH","BK4007"],"gpt_icon":0},{"id":"2477586613","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 早盘大幅上涨5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477586613","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477586613?lang=zh_cn&edition=full","pubTime":"2024-10-21 21:54","pubTimestamp":1729518887,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日21时54分，Reviva Pharmaceuticals Holdings, Inc.股票出现波动，股价快速拉升5.63%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.57%。其相关个股中，Genprex, Inc.、Gri Bio, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，Gri Bio, Inc.、Genprex, Inc.、Windtree Therapeutics, Inc.较为活跃，换手率分别为2205.81%、1454.50%、285.78%，振幅较大的相关个股有Genprex, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Gri Bio, Inc.，振幅分别为176.03%、116.08%、91.38%。Reviva Pharmaceuticals Holdings, Inc.公司简介：Reviva Pharmaceuticals Holdings Inc 是一家后期的制药公司，致力于发现、开发并寻求商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102121544798e3d898&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102121544798e3d898&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVPH","BK4007"],"gpt_icon":0},{"id":"2475646016","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 临近收盘大幅跳水6.91%报1.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475646016","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475646016?lang=zh_cn&edition=full","pubTime":"2024-10-16 03:41","pubTimestamp":1729021282,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日03时41分，Reviva Pharmaceuticals Holdings, Inc.股票出现异动，股价急速跳水6.91%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。其相关个股中，Bright Minds Biosciences Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Bright Minds Biosciences Inc.、Salarius Pharmaceuticals, Inc.、Aditxt, Inc.较为活跃，换手率分别为2129.48%、501.01%、410.74%，振幅较大的相关个股有Bright Minds Biosciences Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Apollomics Inc C/Wts 01/04/2028 ，振幅分别为1204.82%、173.40%、123.44%。Reviva Pharmaceuticals Holdings, Inc.公司简介：Reviva Pharmaceuticals Holdings Inc 是一家后期的制药公司，致力于发现、开发并寻求商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016034122ab6a4f5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016034122ab6a4f5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","RVPH"],"gpt_icon":0},{"id":"2474740206","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 早盘股价大跌5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474740206","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474740206?lang=zh_cn&edition=full","pubTime":"2024-10-10 23:01","pubTimestamp":1728572513,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日23时01分，Reviva Pharmaceuticals Holdings, Inc.股票出现波动，股价大幅跳水5.45%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.48%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Aditxt, Inc.、Tempest Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为288.95%、155.34%、107.98%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Seastar Medical Holding Corp C/Wts 28/10/2027 、Pasithea Therapeutics Corp C/Wts 12/08/2026 ，振幅分别为106.67%、66.67%、49.35%。Reviva Pharmaceuticals Holdings, Inc.公司简介：Reviva Pharmaceuticals Holdings Inc 是一家后期的制药公司，致力于发现、开发并寻求商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101023015398e3bc05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101023015398e3bc05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","RVPH"],"gpt_icon":0},{"id":"2474056724","title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 大幅下跌5.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474056724","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474056724?lang=zh_cn&edition=full","pubTime":"2024-10-09 00:44","pubTimestamp":1728405898,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日00时44分，Reviva Pharmaceuticals Holdings, Inc.股票出现异动，股价大幅跳水5.64%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Bio-Path Holdings, Inc.、Portage Biotech Inc.涨幅较大，Aditxt, Inc.、Bio-Path Holdings, Inc.、Gri Bio, Inc.较为活跃，换手率分别为2488.96%、2377.97%、255.35%，振幅较大的相关个股有Nkgen Biotech Inc C/Wts 31/05/2028、Virios Therapeutics, Inc.、Bio-Path Holdings, Inc.，振幅分别为66.06%、46.27%、45.80%。Reviva Pharmaceuticals Holdings, Inc.公司简介：Reviva Pharmaceuticals Holdings Inc 是一家后期的制药公司，致力于发现、开发并寻求商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009004458a1df1498&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009004458a1df1498&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","RVPH"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.revivapharma.com","stockEarnings":[{"period":"1week","weight":0.27},{"period":"1month","weight":-0.1056},{"period":"3month","weight":0.114},{"period":"6month","weight":-0.1241},{"period":"1year","weight":-0.6833},{"period":"ytd","weight":-0.7534}],"compareEarnings":[{"period":"1week","weight":-0.0177},{"period":"1month","weight":0.0061},{"period":"3month","weight":0.0527},{"period":"6month","weight":0.1101},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.2374}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Reviva Pharmaceuticals Holdings, Inc.于2018年3月20日在英属维尔京群岛注册成立。该公司是一家后期制药公司，致力于发现、开发并寻求将下一代治疗方法商业化，以治疗那些对社会、患者及其家庭具有重大未满足医疗需求和负担的疾病。他们目前的产品线主要集中在中枢神经系统、炎症和心脏代谢疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.098543},{"month":2,"riseRate":0.666667,"avgChangeRate":0.042085},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.036619},{"month":4,"riseRate":0.666667,"avgChangeRate":0.052946},{"month":5,"riseRate":0.166667,"avgChangeRate":-0.156964},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.082378},{"month":7,"riseRate":0,"avgChangeRate":-0.163994},{"month":8,"riseRate":0.5,"avgChangeRate":0.414557},{"month":9,"riseRate":0.5,"avgChangeRate":0.032369},{"month":10,"riseRate":0.5,"avgChangeRate":0.180528},{"month":11,"riseRate":0.571429,"avgChangeRate":-0.008394},{"month":12,"riseRate":0.666667,"avgChangeRate":0.01748}],"exchange":"NASDAQ","name":"Reviva Pharmaceuticals Holdings, Inc.","nameEN":"Reviva Pharmaceuticals Holdings, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Reviva Pharmaceuticals Holdings, Inc.(RVPH)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Reviva Pharmaceuticals Holdings, Inc.(RVPH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Reviva Pharmaceuticals Holdings, Inc.,RVPH,Reviva Pharmaceuticals Holdings, Inc.股票,Reviva Pharmaceuticals Holdings, Inc.股票老虎,Reviva Pharmaceuticals Holdings, Inc.股票老虎国际,Reviva Pharmaceuticals Holdings, Inc.行情,Reviva Pharmaceuticals Holdings, Inc.股票行情,Reviva Pharmaceuticals Holdings, Inc.股价,Reviva Pharmaceuticals Holdings, Inc.股市,Reviva Pharmaceuticals Holdings, Inc.股票价格,Reviva Pharmaceuticals Holdings, Inc.股票交易,Reviva Pharmaceuticals Holdings, Inc.股票购买,Reviva Pharmaceuticals Holdings, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Reviva Pharmaceuticals Holdings, Inc.(RVPH)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Reviva Pharmaceuticals Holdings, Inc.(RVPH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况